YU51101A - Polimorfni oblici telmisartana, postupak za njihovo pripremanje i njihova primena za pripremanje leka - Google Patents

Polimorfni oblici telmisartana, postupak za njihovo pripremanje i njihova primena za pripremanje leka

Info

Publication number
YU51101A
YU51101A YU51101A YUP51101A YU51101A YU 51101 A YU51101 A YU 51101A YU 51101 A YU51101 A YU 51101A YU P51101 A YUP51101 A YU P51101A YU 51101 A YU51101 A YU 51101A
Authority
YU
Yugoslavia
Prior art keywords
preparation
medicament
methods
producing same
telmisartan
Prior art date
Application number
YU51101A
Other languages
English (en)
Inventor
Heinrich Schneider
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Publication of YU51101A publication Critical patent/YU51101A/sh
Publication of RS50044B publication Critical patent/RS50044B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pronalazak se odnosi, na polimorfne oblike 4'-[2-n-propil-4-metil-6-(1-metilbenzimidazol-2-il)benzimidazol-1-ilmetil]bifenil-2-karbonske kiseline (INN: telmisartan), naročito na polimorfni oblik B (I), naznačen time, što se pri termičkoj analizi pomoću DSC javlja endotermni maksimum na 182В±2В°C, na smeše polimorfnih oblika, na postupak za pripremanje telmisartina koji sadrži oblik B, kao i na njegovu primenu u pripremanju leka.
YUP-511/01A 1999-01-19 2000-01-07 Polimorfni oblici telmisartana, postupak za njihovo pripremanje i njihova primena za pripremanje leka RS50044B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (de) 1999-01-19 1999-01-19 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels

Publications (2)

Publication Number Publication Date
YU51101A true YU51101A (sh) 2004-05-12
RS50044B RS50044B (sr) 2008-11-28

Family

ID=7894715

Country Status (36)

Country Link
EP (1) EP1144386B1 (sh)
JP (1) JP4700813B2 (sh)
KR (1) KR100658959B1 (sh)
CN (1) CN1144790C (sh)
AR (1) AR035475A1 (sh)
AT (1) ATE252564T1 (sh)
AU (1) AU765081B2 (sh)
BG (1) BG65027B1 (sh)
BR (1) BR0007584A (sh)
CA (1) CA2352436C (sh)
CO (1) CO5150238A1 (sh)
CZ (1) CZ297412B6 (sh)
DE (2) DE19901921C2 (sh)
DK (1) DK1144386T3 (sh)
EA (1) EA003065B1 (sh)
EE (1) EE04344B1 (sh)
ES (1) ES2208265T3 (sh)
HK (1) HK1041485B (sh)
HR (1) HRP20010514B1 (sh)
HU (1) HU227401B1 (sh)
IL (2) IL143634A0 (sh)
MY (1) MY122755A (sh)
NO (1) NO319823B1 (sh)
NZ (1) NZ513528A (sh)
PE (1) PE20001362A1 (sh)
PL (1) PL211829B1 (sh)
PT (1) PT1144386E (sh)
RS (1) RS50044B (sh)
SA (1) SA99200838B1 (sh)
SK (1) SK285429B6 (sh)
TR (1) TR200102074T2 (sh)
TW (1) TWI280241B (sh)
UA (1) UA56358C2 (sh)
UY (1) UY25980A1 (sh)
WO (1) WO2000043370A1 (sh)
ZA (1) ZA200104771B (sh)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153737A1 (de) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
PT1467712E (pt) 2002-01-16 2008-01-09 Boehringer Ingelheim Pharma Comprimido farmacêutico de duas camadas compreendendo telmisartan e hidroclorotiazida
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
JP2008503595A (ja) 2004-10-15 2008-02-07 テバ ファーマシューティカル インダストリーズ リミティド テルミサルタンの調製方法
WO2006044754A2 (en) 2004-10-18 2006-04-27 Dr. Reddy's Laboratories Ltd. Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
MX346039B (es) 2009-05-20 2017-03-03 Boehringer Ingelheim Vetmedica Gmbh Solucion farmaceutica bebible de telmisartan.
PL2443094T3 (pl) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Sposób wytwarzania telmisartanu
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
EP2448576A2 (en) 2009-07-02 2012-05-09 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EP2632438A1 (en) 2010-10-27 2013-09-04 KRKA, tovarna zdravil, d.d., Novo mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (it) * 2010-12-27 2012-06-28 Chemelectiva S R L Intermedio per la preparazione di un principio attivo e processo per la sua preparazione
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (ja) * 2013-04-10 2017-06-14 株式会社トクヤマ 酢酸が低減されたテルミサルタンａ型結晶の製造方法
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (ja) * 2014-09-03 2018-02-07 株式会社トクヤマ テルミサルタンのアンモニウム塩の製造方法
JP5871294B1 (ja) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 即時放出経口錠剤
KR20170001921A (ko) 2015-06-26 2017-01-05 대원제약주식회사 안정성이 개선된 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법
KR20170012703A (ko) 2015-07-22 2017-02-03 대원제약주식회사 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법
JP6411662B2 (ja) 2016-05-30 2018-10-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 固定容量配合剤
KR102044223B1 (ko) * 2016-09-12 2019-11-13 성균관대학교산학협력단 텔미사르탄을 포함하는 고체 분산체 및 이의 제조방법
CN106749037B (zh) * 2016-12-21 2019-06-21 山东大学 一种无定型的替米沙坦-戊二酸共晶及其制备方法和应用
CN106749036B (zh) * 2016-12-21 2019-06-21 山东大学 一种无定型的替米沙坦-庚二酸共晶及其制备方法和应用
CA3067918A1 (en) 2017-07-07 2019-01-10 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonish for the prevention or treatment of hypertension in cats
CN109851562A (zh) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 一种替米沙坦晶体及其制备方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
HUP0105148A2 (hu) 2002-07-29
DE19901921A1 (de) 2000-08-03
KR100658959B1 (ko) 2006-12-19
PL349425A1 (en) 2002-07-29
CZ297412B6 (cs) 2006-12-13
ZA200104771B (en) 2002-12-02
HK1041485B (zh) 2004-10-08
UA56358C2 (uk) 2003-05-15
ES2208265T3 (es) 2004-06-16
NO319823B1 (no) 2005-09-19
CN1336920A (zh) 2002-02-20
HRP20010514A2 (en) 2002-08-31
DE19901921C2 (de) 2001-01-04
NO20013560L (no) 2001-09-18
DE50004150D1 (de) 2003-11-27
EE04344B1 (et) 2004-08-16
ATE252564T1 (de) 2003-11-15
BR0007584A (pt) 2001-11-06
PE20001362A1 (es) 2000-12-15
MY122755A (en) 2006-05-31
IL143634A0 (en) 2002-04-21
KR20010101552A (ko) 2001-11-14
AR035475A1 (es) 2004-06-02
BG65027B1 (bg) 2006-12-29
RS50044B (sr) 2008-11-28
JP2002535315A (ja) 2002-10-22
BG105654A (en) 2002-01-31
EP1144386B1 (de) 2003-10-22
SK285429B6 (sk) 2007-01-04
EE200100375A (et) 2002-10-15
EP1144386A1 (de) 2001-10-17
CN1144790C (zh) 2004-04-07
PT1144386E (pt) 2004-03-31
NZ513528A (en) 2003-08-29
SA99200838B1 (ar) 2006-03-06
EA003065B1 (ru) 2002-12-26
JP4700813B2 (ja) 2011-06-15
TR200102074T2 (tr) 2001-12-21
SK10202001A3 (sk) 2001-12-03
IL143634A (en) 2006-10-05
HU227401B1 (en) 2011-05-30
HRP20010514B1 (en) 2010-01-31
TWI280241B (en) 2007-05-01
CO5150238A1 (es) 2002-04-29
AU765081B2 (en) 2003-09-11
HUP0105148A3 (en) 2003-01-28
CA2352436A1 (en) 2000-07-27
CZ20012634A3 (cs) 2001-10-17
WO2000043370A1 (de) 2000-07-27
EA200100730A1 (ru) 2002-02-28
NO20013560D0 (no) 2001-07-18
UY25980A1 (es) 2001-08-27
DK1144386T3 (da) 2004-01-12
AU2288100A (en) 2000-08-07
PL211829B1 (pl) 2012-06-29
CA2352436C (en) 2010-03-23
HK1041485A1 (en) 2002-07-12

Similar Documents

Publication Publication Date Title
YU51101A (sh) Polimorfni oblici telmisartana, postupak za njihovo pripremanje i njihova primena za pripremanje leka
ZA202205346B (en) Glp-1 receptor agonist and use thereof
CU23105A3 (es) DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS
TW200509914A (en) Pharmaceutical formulation of the telmisartan sodium salt
AR023401A1 (es) Derivados de 1,4-benzotiazepina-1,1-dioxido sustituidos con restos de azucar, procedimientos para su preparacion, medicamentos que contienen estoscompuestos, y su empleo para preparar un medicamento
BR0113234A (pt) Polimorfos de um análogo de epotilona
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
BR0308212A (pt) Composto, composição farmacêutica, e, uso de um composto
BR122019010008B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
BRPI0412314A (pt) derivados de pirimidina-2,4-diona como antagonistas de receptor de hormÈnio liberador de gonadotropina
AR037148A1 (es) Sal sodica cristalina,procedimiento para su preparacion y su uso para la preparacion de un medicamento.
DE69928226D1 (de) Chemokin rezeptor antagonisten und verwndung
AR024440A1 (es) AGONISTAS DEL RECEPTOR A2A DE ETER PROPARGIL FENILICO, COMPOSICIoN FARMACEUTICA Y EL USO DE LOS MISMOS PARA PREPARAR UN MEDICAMENTO.
NO20044041L (no) Okso-azabisykliske forbindelser
EA200200096A1 (ru) Новые производные витамина d с циклическими субструктурами в боковых цепях, способ и промежуточные продукты для их получения и их применение для получения лекарственных средств
ES2191099T3 (es) Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
AR001769A1 (es) Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación
BR0309668A (pt) Imidazolinilmetil aralquilsulfonamidas
SE0101978D0 (sv) New compounds
AR037427A1 (es) Compuesto de quinolina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento para prepararlo y compuestos de quinolina de utilidad como intermediarios en dicho procedimiento
BR9915323A (pt) Derivados pirimidina e processos para sua preparação
AR026451A1 (es) Compuestos heterociclicos sililados
ECSP993250A (es) Polimorfos de telmisartan, procedimiento para su preparacion y su empleo para la preparacion de un medicamento
AR020142A1 (es) Un compuesto derivado de arginina, una composicion farmaceutica que los comprende y el uso de los mismos para la manufactura de un medicamento paraantagonizar un receptor para c3a